1733420
Last Update Posted: 2021-11-22
Recruiting has ended
All Genders accepted | 2 Years-9 Years |
120 Estimated Participants | No Expanded Access |
Interventional Study | Accepts healthy volunteers |
Biodentine Versus White MTA Pulpotomy
A clinical trial to evaluate and compare three different products used for endodontic treatment (taking the infected nerve out of the teeth) of primary teeth.
Null Hypothesis: The new biological products (WMTA and Biodentine) behave as good as the former iodoform product.
Eligibility
Relevant conditions:
Extensive Decay in Primary Molars
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
No valid contacts available
Data sourced from ClinicalTrials.gov